Exo1 independent DNA mismatch repair involves multiple compensatory nucleases

DNA Repair

Volumn 21, Issue , 2014, Pages 55-64

  Desai, Amar ^a   Gerson, Stanton ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

DNA repair; Exonuclease 1; Mismatch repair; Temozolomide

Indexed keywords

6 O BENZYLGUANINE; ARTEMIS PROTEIN; COMPLEMENTARY DNA; EXONUCLEASE; EXONUCLEASE 1; FAN1 PROTEIN; HETERODUPLEX; MRE11 PROTEIN; NUCLEASE; PEPTIDES AND PROTEINS; SHORT HAIRPIN RNA; TEMOZOLOMIDE; UNCLASSIFIED DRUG; DACARBAZINE; DCLRE1C PROTEIN, MOUSE; DEOXYRIBONUCLEASE; DNA BINDING PROTEIN; DNA LIGASE; ENDONUCLEASE; EXO1 PROTEIN, MOUSE; EXODEOXYRIBONUCLEASE; FAN1 PROTEIN, MOUSE; GUANINE; MRE11A PROTEIN, MOUSE; NUCLEAR PROTEIN; O(6)-BENZYLGUANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MUTANT; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC STABILITY; GENOMIC INSTABILITY; HEK293 CELL LINE; HEMATOPOIETIC STEM CELL; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; IN VITRO STUDY; IN VIVO STUDY; MISMATCH REPAIR; MOUSE; MOUSE MODEL; MTT ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TARGET CELL; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL LINE; DRUG EFFECTS; FIBROBLAST; GENETICS; METABOLISM;

MAMMALIA;

ANIMALS; CELL LINE; DACARBAZINE; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDODEOXYRIBONUCLEASES; ENDONUCLEASES; EXODEOXYRIBONUCLEASES; FIBROBLASTS; GUANINE; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; UP-REGULATION;

EID: 84905398242     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.06.005     Document Type: Article

References (50)

1. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 1996, 65:101-133.
2. Li G.M. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008, 18(1):85-98.
3. Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 2006, 7(5):335-346.
4. Kunkel T.A., Erie D.A. DNA mismatch repair. Annu. Rev. Biochem. 2005, 74:681-710.
5. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 2003, 21(6):1174-1179.
6. Kolodner R.D. Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 1995, 20(10):397-401.
7. Marra G., Boland C.R. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 1995, 87(15):1114-1125.
8. Kadyrov F.A., et al. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 2006, 126(2):297-308.
9. Jascur T., Boland C.R. Structure and function of the components of the human DNA mismatch repair system. Int. J. Cancer 2006, 119(9):2030-2035.
10. Iyer R.R., et al. The MutSalpha-proliferating cell nuclear antigen interaction in human DNA mismatch repair. J. Biol. Chem. 2008, 283(19):13310-13319.
11. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 1996, 10(12):1433-1442.
12. Schofield M.J., Hsieh P. DNA mismatch repair: molecular mechanisms and biological function. Annu. Rev. Microbiol. 2003, 57:579-608.
13. Klapacz J., et al. O6-methylguanine-induced cell death involves exonuclease 1 as well as DNA mismatch recognition in vivo. Proc. Natl. Acad. Sci U. S. A. 2009, 106(2):576-581.
14. Schaetzlein S., et al. Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell 2007, 130(5):863-877.
15. Maringele L., Lydall D. EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants. Genes Dev. 2002, 16(15):1919-1933.
16. Genschel J., Bazemore L.R., Modrich P. Human exonuclease I is required for 5' and 3' mismatch repair. J. Biol. Chem. 2002, 277(15):13302-13311.
17. Tran P.T., et al. EXO1-A multi-tasking eukaryotic nuclease. DNA Repair (Amst.) 2004, 3(12):1549-1559.
18. Pluciennik A., et al. PCNA function in the activation and strand direction of MutLalpha endonuclease in mismatch repair. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(37):16066-16071.
19. Liberti S.E., Larrea A.A., Kunkel T.A. Exonuclease 1 preferentially repairs mismatches generated by DNA polymerase alpha. DNA Repair (Amst.) 2013, 12(2):92-96.
20. Kuismanen S.A., et al. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am. J. Pathol. 2000, 156(5):1773-1779.
21. Russo A., et al. Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients. Tumori 2009, 95(6):731-738.
22. Jagmohan-Changur S., et al. EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer. Cancer Res. 2003, 63(1):154-158.
23. Thompson E., et al. Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clin. Genet. 2004, 65(3):215-225.
24. Liberti S.E., Rasmussen L.J. Is hEXO1 a cancer predisposing gene?. Mol. Cancer Res. 2004, 2(8):427-432.
25. Wei K., et al. Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev. 2003, 17(5):603-614.
26. Burdett V., et al. In vivo requirement for RecJ, ExoVII, ExoI, and ExoX in methyl-directed mismatch repair. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(12):6765-6770.
27. Reese J.S., Liu L., Gerson S.L. Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 2003, 102(5):1626-1633.
28. Vlachostergios P.J., Hatzidaki E., Papandreou C.N. MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFkappaB and mutant p53. Neurol. Res. 2013, 35(8):879-882.
29. van Meerloo J., Kaspers G.J., Cloos J. Cell sensitivity assays: the MTT assay. Methods Mol. Biol. 2011, 731:237-245.
30. Zhou B., et al. Preparation of heteroduplex enhanced green fluorescent protein plasmid for in vivo mismatch repair activity assay. Anal. Biochem. 2009, 388(1):167-169.
31. Tichy E.D., et al. Mismatch and base excision repair proficiency in murine embryonic stem cells. DNA Repair (Amst.) 2011, 10(4):445-451.
32. Mohni K.N., et al. DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication. J. Virol. 2011, 85(23):12241-12253.
33. Claij N., Te Riele H. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level. Oncogene 2002, 21(18):2873-2879.
34. Fu D., Calvo J.A., Samson L.D. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat. Rev. Cancer 2012, 12(2):104-120.
35. Newlands E.S., et al. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat. Rev. 1997, 23(1):35-61.
36. Giannini G., et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep. 2002, 3(3):248-254.
37. Her C., Vo A.T., Wu X. Evidence for a direct association of hMRE11 with the human mismatch repair protein hMLH1. DNA Repair (Amst.) 2002, 1(9):719-729.
38. Vo A.T., et al. hMRE11 deficiency leads to microsatellite instability and defective DNA mismatch repair. EMBO Rep. 2005, 6(5):438-444.
39. Gaymes T.J., et al. Microsatellite instability induced mutations in DNA repair genes CtIp and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors in myeloid malignancies. Haematologica 2013, 98(9):1397-1406.
40. Yoshikiyo K., et al. KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(50):21553-21557.
41. Smogorzewska A., et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 2010, 39(1):36-47.
42. Katsube T., et al. Differences in sensitivity to DNA-damaging Agents between XRCC4- and Artemis-deficient human cells. J. Radiat. Res. 2011, 52(4):415-424.
43. Wyatt M.D., Pittman D.L. Methylating agents and DNA repair responses: methylated bases and sources of strand breaks. Chem. Res. Toxicol. 2006, 19(12):1580-1594.
44. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 1990, 231(1):11-30.
45. Weller M., et al. MGMT promoter methylation in malignant gliomas: ready for personalized medicine?. Nat. Rev. Neurol. 2010, 6(1):39-51.
46. Lee B.I., et al. Expression specificity of the mouse exonuclease 1 (mExo1) gene. Nucleic Acids Res. 1999, 27(20):4114-4120.
47. Desai A., Qing Y., Gerson S.L. Exonuclease 1 is a critical mediator of survival during DNA double strand break repair in nonquiescent hematopoietic stem and progenitor cells. Stem Cells 2014, 32(2):582-593.
48. Kadyrov F.A., et al. A possible mechanism for exonuclease 1-independent eukaryotic mismatch repair. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(21):8495-8500.
49. Izumchenko E., Saydi J., Brown K.D. Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents. DNA Repair (Amst.) 2011, 11(12):951-964.
50. Schaetzlein S., et al. Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(27):E2470-E2479.